Medicine and Dentistry
Aboriginal and Torres Strait Islander
12%
Acute Coronary Syndrome
14%
Adverse Event
31%
Aged Care
13%
All Cause Mortality
15%
Apoplexy
65%
Arm
19%
Asthma
14%
Atherosclerosis
20%
Atrial Fibrillation
28%
Awareness
13%
Biological Marker
41%
Blood Pressure
57%
Body Mass Index
28%
Bone Density
20%
Brain Ischemia
14%
Breast Cancer
15%
Cancer
17%
Cardiovascular Disease
76%
Cardiovascular Risk
31%
Cardiovascular System
58%
Chronic Kidney Disease
21%
Clinical Trial
52%
Clinician
31%
Cohort Analysis
42%
Cohort Effect
12%
Comorbidity
27%
Computer Assisted Tomography
14%
Congestive Heart Failure
19%
Coronary Artery Disease
24%
Cost-Effectiveness Analysis
19%
COVID-19
40%
Cross Sectional Study
22%
Diabetes
91%
Diabetes Mellitus
12%
Diseases
100%
Drug Therapy
13%
Dyslipidemia
13%
Emergency Department
18%
Familial Hypercholesterolemia
60%
Fibrosis
15%
Frailty
22%
Gene Linkage
13%
Global Disease Burden
16%
Glomerular Filtration Rate
16%
Hazard Ratio
44%
Health Care Cost
47%
Health Outcomes
13%
Idiopathic Pulmonary Fibrosis
16%
Infection
47%
Insulin Dependent Diabetes Mellitus
13%
Intensive Care
14%
Intensive Care Unit
29%
Kidney Denervation
27%
Kidney Function
14%
Kidney Graft
25%
Kidney Transplantation
17%
Lipoprotein
35%
Logistic Regression Analysis
12%
Low Density Lipoprotein Cholesterol
27%
Lung
20%
Lung Cancer
15%
Malignant Neoplasm
51%
Maturity Onset Diabetes of the Young
68%
Medicine
22%
Melanoma
28%
Mesothelioma
28%
Meta-Analysis
61%
Metabolic Syndrome
17%
Mortality Rate
12%
Myocardial Infarction
18%
Neoplasm
44%
Nivolumab
13%
Nonalcoholic Fatty Liver
24%
Observational Study
28%
Odds Ratio
39%
Overall Survival
22%
Pediatrics
14%
Peritoneal Dialysis
22%
Physical Activity
18%
Placebo
51%
Pleura Effusion
17%
Pleura Mesothelioma
25%
Positron Emission Tomography
16%
Positron Emission Tomography-Computed Tomography
14%
Prevalence
55%
Proportional Hazards Model
16%
Prospective Cohort Study
26%
Prostate Cancer
25%
Public Health
16%
Quality of Life
52%
Randomized Clinical Trial
24%
Randomized Controlled Trial
91%
Recurrent Disease
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Statin
18%
Sympathetic Nervous System
14%
Systematic Review
76%
Systolic Blood Pressure
17%
Triacylglycerol
15%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
11%
Acute Coronary Syndrome
8%
Adverse Event
35%
All Cause Mortality
22%
Antibiotics
8%
Antihypertensive Agent
18%
Antimalarial Agent
14%
Antioxidant
10%
Apolipoprotein
9%
Artesunate
11%
Asthma
8%
Atherosclerosis
11%
Atrial Fibrillation
21%
Benzathine Penicillin
10%
Bile Acid
14%
Biological Marker
32%
Cardiovascular Disease
69%
Cardiovascular Mortality
8%
Cardiovascular Risk
23%
Cerebrovascular Accident
38%
Chemotherapy
25%
Chronic Kidney Failure
16%
Clinical Trial
43%
Cohort Study
27%
Colchicine
10%
Combination Therapy
17%
Comorbidity
23%
Congestive Heart Failure
18%
Coronary Artery Atherosclerosis
24%
Coronary Artery Disease
19%
Cross-Sectional Study
9%
Dexamethasone
12%
Diabetes Mellitus
11%
Dihydroartemisinin
15%
Diseases
83%
Dyslipidemia
12%
Familial Hypercholesterolemia
29%
Fibrosing Alveolitis
14%
Fibrosis
10%
Flavonoid
11%
Frailty
11%
Global Disease Burden
14%
Heart Infarction
16%
High Density Lipoprotein
8%
High Density Lipoprotein Cholesterol
14%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
19%
Immunotherapy
9%
Infection
41%
Inflammation
24%
Inflammatory Arthritis
11%
Insulin Resistance
9%
Ipilimumab
11%
Iron
9%
Ischemic Heart Disease
13%
Isoprostane Derivative
13%
Lipoprotein
32%
Lipoprotein A
44%
Low Density Lipoprotein Cholesterol
27%
Lung Cancer
11%
Lutetium 177
8%
Malaria Falciparum
14%
Malignant Neoplasm
38%
Melanoma
19%
Mesothelioma
19%
Metabolic Syndrome X
21%
Monotherapy
18%
Nanoparticle
11%
Neoplasm
36%
Nitric Oxide
9%
Nivolumab
14%
Non Insulin Dependent Diabetes Mellitus
45%
Nonalcoholic Fatty Liver
15%
Normal Human
9%
Observational Study
16%
Overall Survival
19%
Pharmacodynamics
10%
Pharmacokinetics
38%
Pharmacotherapy
12%
Piperaquine
8%
Placebo
60%
Pleura Mesothelioma
17%
Polyethylene Terephthalate
11%
Prevalence
41%
Progression Free Survival
13%
Proprotein Convertase 9
9%
Prospective Cohort Study
17%
Prostate Cancer
11%
Randomized Clinical Trial
22%
Randomized Controlled Trial
48%
Recurrent Disease
14%
Remission
11%
Resistant Hypertension
9%
Rheumatic Heart Disease
13%
Rheumatoid Arthritis
11%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Solid Malignant Neoplasm
14%
Statin (Protein)
28%
Tolerability
15%
Triacylglycerol
25%
Vitamin D
9%
Nursing and Health Professions
Adolescent
8%
Adverse Event
6%
Aged Care
18%
All Cause Mortality
6%
Antihypertensive Agent
7%
Atrial Fibrillation
7%
Biological Marker
5%
Blood Pressure
29%
Body Composition
7%
Body Mass
10%
Cardiovascular Disease
27%
Cardiovascular Risk
6%
Catheter
6%
Cerebrovascular Accident
28%
Chronic Kidney Failure
9%
Clinical Audit
7%
Clinical Outcome
5%
Clinical Practice
6%
Cognitive Defect
8%
Cohort Analysis
15%
Combination Therapy
5%
Comorbidity
8%
Confidence Interval
38%
Congestive Heart Failure
9%
Coronary Artery Disease
8%
Cost Effectiveness Analysis
9%
Critical Illness
5%
Cross-Sectional Study
6%
Cystic Fibrosis
6%
Deprescribing
6%
Depressive Disorder
6%
Diseases
28%
Emergency Ward
8%
Familial Hypercholesterolemia
13%
Foot Ulcer
5%
Frailty
19%
General Practice
7%
General Practitioner
7%
Glucose Blood Level
5%
Grip Strength
5%
Hazard Ratio
15%
Health Care
10%
Health Care Cost
5%
Health Care Personnel
15%
Health Outcomes
8%
Health Practitioner
12%
Hearing Impairment
5%
Heart Infarction
7%
Hemoglobin A1c
6%
Hospital Discharge
11%
Hospital Mortality
6%
Hospital Readmission
10%
Imaging
6%
Infection
13%
Inflammatory Arthritis
6%
Intensive Care
12%
Intensive Care Unit
28%
Kidney Denervation
9%
Kidney Graft
5%
Length of Stay
7%
Lipoprotein A
6%
Logistic Regression Analysis
10%
Longitudinal Analysis
5%
Low Density Lipoprotein Cholesterol
7%
Malignant Neoplasm
18%
Meta Analysis
23%
Mild Cognitive Impairment
6%
Model of Care
7%
Mortality Rate
5%
Motor Neuron Disease
8%
Muscle Strength
6%
Non Insulin Dependent Diabetes Mellitus
22%
Nutrition Policy
6%
Odds Ratio
26%
Outpatient
5%
Palliative Therapy
11%
Pandemic
6%
Patient Referral
7%
Patient-Reported Outcome
5%
Peritoneal Dialysis
14%
Peritonitis
7%
Pilot Study
7%
Placebo
13%
Pleura Mesothelioma
6%
Practice Guideline
22%
Prematurity
5%
Prevalence
23%
Primary Medical Care
7%
Proportional Hazards Model
7%
Prospective Cohort Study
7%
Quality of Life
27%
Rate Ratio
5%
Rheumatoid Arthritis
6%
Statin (Protein)
5%
Systematic Review
36%
Systolic Blood Pressure
5%
Treatment Outcome
5%
Volunteer
7%
Ward
6%